Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ELF1 encodes an E26 transformation-specific related transcription factor. Additionally we are shipping ELF1 Proteins (5) and ELF1 Kits (2) and many more products for this protein.
Showing 10 out of 89 products:
Dog (Canine) Polyclonal ELF1 Primary Antibody for WB - ABIN2779831
Geng, Laslo, Barton, Wang: Transcriptional regulation of CD1D1 by Ets family transcription factors. in Journal of immunology (Baltimore, Md. : 1950) 2005
Human Polyclonal ELF1 Primary Antibody for ELISA, WB - ABIN249591
Wang, Petryniak, Thompson, Kaelin, Leiden: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. in Science (New York, N.Y.) 1993
Horse (Equine) Polyclonal ELF1 Primary Antibody for WB - ABIN2792625
Andrews, Kennedy, Popadiuk, Kao: Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1. in Molecular cancer research : MCR 2008
Herein, the authors demonstrate that mice lacking Sts (show STS Antibodies) expression are significantly resistant to infection by the live vaccine strain of Francisella tularensis.
Whereas the proportion of NK cells in Elf-1 (show EFNA2 Antibodies)(-/-) mice was normal, the proportion of NKT (show CTSL1 Antibodies) cells was significantly reduced in the thymus and periphery of Elf-1 (show EFNA2 Antibodies)(-/-) mice compared with wild-type mice.
crystal structure of the phosphatase domain of Sts-1 (show STS1 Antibodies), Sts-1 (show STS1 Antibodies)(PGM (show Vcan Antibodies)), was determined at pH 4.6.The asymmetric unit contains two independent molecules and each active site is occupied by a sulfate ion.
Results suggest that GATA-2 (show GATA2 Antibodies), Fli-1 (show FLI1 Antibodies) and Elf-1 (show EFNA2 Antibodies) are key components of an enhanceosome responsible for activating SCL (show TAL1 Antibodies) transcription and establishing the transcriptional programme required for HSC (show FUT1 Antibodies) formation.
These results suggest that several Ets (show ETS1 Antibodies) factors, including Fli1 (show FLI1 Antibodies) itself, are involved in the transcriptional regulation of Fli1 (show FLI1 Antibodies) in lymphocytes.
The Sts-1,2 proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways.
ELF1 (show EFNA2 Antibodies) binding occurs at both TERT (show TERT Antibodies) promoter mutations in melanoma in vitro such that increased recruitment of GABP is enabled by the spatial architecture of native and novel ETS (show ETS1 Antibodies) motifs in the TERT (show TERT Antibodies) promoter region.
ELF-1 (show EFNA2 Antibodies) binds an important duplicated GGAA cis (show CISH Antibodies)-acting element at the OAS1 (show OAS1 Antibodies) promoter and in cooperation with RB1 (show RB1 Antibodies) and SP1 (show PSG1 Antibodies) recruitment contributes to regulation in response to IFN stimulation.
Data suggest that Elf-1 (show EFNA2 Antibodies) may modulate breast cancer progression to some extent without having an impact on survival of breast cancer patients.
Expression of FLI-1 (show FLI1 Antibodies), ELF-1 (show EFNA2 Antibodies), and GABP activated the PF4 (show PF4 Antibodies) promoter in HepG2 cells.
The expression of Elf-1 (show EFNA2 Antibodies) and survivin (show BIRC5 Antibodies) in non-small cell lung cancer is related to differentiation, lymphatic metastasis, clinical stage, and prognosis, and both are positively correlated with microvessel density.
the results indicate that insufficient O-GlcNAc (show OGT Antibodies) modification prevents Elf-1 (show EFNA2 Antibodies)-mediated transcriptional repression and thereby upregulates Tollip (show TOLLIP Antibodies) gene expression in intestinal epithelial cells.
through a genome-wide association in a Hong Kong Chinese cohort and replication in 2 other Asian populations, identified association of ELF1 (show EFNA2 Antibodies) with systemic lupus erythematosus
The expression levels of both Elf-1 and VEGF were significantly related with tumor differentiation, lymphatic metastasis, clinical stage, and postoperative survival time in non-small cell lung cancer.
ETS transcription factor (show FEV Antibodies) ELF1 (show EFNA2 Antibodies) is an important positive regulator of MEIS1 (show MEIS1 Antibodies) expression
Data show that VEGFR1 (show FLT1 Antibodies) promoter binding sites for ELF-1 (show EFNA2 Antibodies), CREB (show CREB1 Antibodies) and EGR-1 (show EGR1 Antibodies)/3 play a positive role in gene transcription in endothelial cells.
This gene encodes an E26 transformation-specific related transcription factor. The encoded protein is primarily expressed in lymphoid cells and acts as both an enhancer and a repressor to regulate transcription of various genes. Alternative splicing results in multiple transcript variants.
ETS-related transcription factor Elf-1
, E74-like factor 1 (ets domain transcription factor)